NIKA PHARMACEUTICALS, INC. Cash and Restricted Cash
NIKA PHARMACEUTICALS, INC. (NIKA) had Cash and Restricted Cash of $2.93 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-10
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.93K.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.53K.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.89K.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.29K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $2.93K 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $1.53K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $1.89K 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $6.29K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $15.62K 10-Q · filed 2026-08-10 | |
| 2025-03-31 | $19.14K 10-Q · filed 2026-05-12 | |
| 2024-12-31 | $2.08K 10-Q · filed 2026-08-10 | |
| 2024-09-30 | $1.39K 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $4.75K 10-Q · filed 2025-08-14 | $7.49K 10-Q · filed 2024-09-18 |
| 2024-03-31 | $19.60K 10-Q · filed 2025-05-13 | $24.47K 10-Q · filed 2024-05-28 |
| 2023-12-31 | $19.60K 10-K · filed 2026-03-25 | |
| 2023-09-30 | $10.91K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $11.05K 10-Q/A · filed 2024-11-01 | |
| 2023-03-31 | $4.46K 10-Q · filed 2024-05-28 | |
| 2022-12-31 | $864.00 10-K · filed 2025-03-31 | |
| 2022-09-30 | $3.91K 10-Q · filed 2023-10-31 | |
| 2022-06-30 | $8.54K 10-Q · filed 2023-08-21 | |
| 2021-12-31 | $399.00 10-K · filed 2024-04-01 | |
| 2021-06-30 | $398.00 10-Q/A · filed 2022-11-07 | |
| 2020-12-31 | $1.61K 10-Q/A · filed 2022-11-07 |